Black Hairy Tongue Associated with Erlotinib Treatment in a Patient with Advanced Lung Cancer

Erlotinib is a tyrosine kinase inhibitor that acts on the epidermal growth factor receptor (EGFR). There have been many reports of the mucocutaneous side effects related to several EGFR inhibitors (EGFRIs). However, no case of black hairy tongue (BHT) associated with EGFRI has been reported. Herein,...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Jin Seob, Lee, Ji Yeoun, Kim, Mi Kyeong, Yoon, Tae Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229953/
https://www.ncbi.nlm.nih.gov/pubmed/22148027
http://dx.doi.org/10.5021/ad.2011.23.4.526
_version_ 1782218009781207040
author Jeong, Jin Seob
Lee, Ji Yeoun
Kim, Mi Kyeong
Yoon, Tae Young
author_facet Jeong, Jin Seob
Lee, Ji Yeoun
Kim, Mi Kyeong
Yoon, Tae Young
author_sort Jeong, Jin Seob
collection PubMed
description Erlotinib is a tyrosine kinase inhibitor that acts on the epidermal growth factor receptor (EGFR). There have been many reports of the mucocutaneous side effects related to several EGFR inhibitors (EGFRIs). However, no case of black hairy tongue (BHT) associated with EGFRI has been reported. Herein, we report the first case of erlotinib-induced BHT in a 61-year-old man with advanced lung cancer. Considering recent use of EGFRIs worldwide, dermatologists should recognize the possible occurrence of BHT associated with EGFRIs such as erlotinib.
format Online
Article
Text
id pubmed-3229953
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Korean Dermatological Association; The Korean Society for Investigative Dermatology
record_format MEDLINE/PubMed
spelling pubmed-32299532011-12-06 Black Hairy Tongue Associated with Erlotinib Treatment in a Patient with Advanced Lung Cancer Jeong, Jin Seob Lee, Ji Yeoun Kim, Mi Kyeong Yoon, Tae Young Ann Dermatol Case Report Erlotinib is a tyrosine kinase inhibitor that acts on the epidermal growth factor receptor (EGFR). There have been many reports of the mucocutaneous side effects related to several EGFR inhibitors (EGFRIs). However, no case of black hairy tongue (BHT) associated with EGFRI has been reported. Herein, we report the first case of erlotinib-induced BHT in a 61-year-old man with advanced lung cancer. Considering recent use of EGFRIs worldwide, dermatologists should recognize the possible occurrence of BHT associated with EGFRIs such as erlotinib. Korean Dermatological Association; The Korean Society for Investigative Dermatology 2011-11 2011-11-03 /pmc/articles/PMC3229953/ /pubmed/22148027 http://dx.doi.org/10.5021/ad.2011.23.4.526 Text en Copyright © 2011 Korean Dermatological Association; The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Jeong, Jin Seob
Lee, Ji Yeoun
Kim, Mi Kyeong
Yoon, Tae Young
Black Hairy Tongue Associated with Erlotinib Treatment in a Patient with Advanced Lung Cancer
title Black Hairy Tongue Associated with Erlotinib Treatment in a Patient with Advanced Lung Cancer
title_full Black Hairy Tongue Associated with Erlotinib Treatment in a Patient with Advanced Lung Cancer
title_fullStr Black Hairy Tongue Associated with Erlotinib Treatment in a Patient with Advanced Lung Cancer
title_full_unstemmed Black Hairy Tongue Associated with Erlotinib Treatment in a Patient with Advanced Lung Cancer
title_short Black Hairy Tongue Associated with Erlotinib Treatment in a Patient with Advanced Lung Cancer
title_sort black hairy tongue associated with erlotinib treatment in a patient with advanced lung cancer
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229953/
https://www.ncbi.nlm.nih.gov/pubmed/22148027
http://dx.doi.org/10.5021/ad.2011.23.4.526
work_keys_str_mv AT jeongjinseob blackhairytongueassociatedwitherlotinibtreatmentinapatientwithadvancedlungcancer
AT leejiyeoun blackhairytongueassociatedwitherlotinibtreatmentinapatientwithadvancedlungcancer
AT kimmikyeong blackhairytongueassociatedwitherlotinibtreatmentinapatientwithadvancedlungcancer
AT yoontaeyoung blackhairytongueassociatedwitherlotinibtreatmentinapatientwithadvancedlungcancer

Ejemplares similares